Skip to main content

MoneyWorks4Me

Balaxi Pharmaceuticals’ arm completes acquisition of 99% stake in BHES

08 Nov 2021 Evaluate

Balaxi Pharmaceuticals’ wholly owned subsidiary -- Balaxi Global DMCC, Dubai (BGD), has completed acquisition of 99% shares of Balaxi Healthcare El Salvador, S.A DE C.V, El Salvador, Central America (BHES), which has consequently become the step-down subsidiary of Balaxi Pharmaceuticals.

Balaxi Pharmaceuticals operates as an investment company in India.

Peers
Company Name CMP
Redington 349.60
Adani Enterprises 2682.00
Amrapali Industries 32.78
Maxgrow India 174.80
Rashi Peripheral 689.15
View more..